As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Subscribe To Our Newsletter & Stay Updated
